Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Jun 09, 2021

SELL
$20.53 - $25.22 $431 - $529
-21 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$18.39 - $24.8 $386 - $520
21 New
21 $0

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Tompkins Financial Corp Portfolio

Follow Tompkins Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Tompkins Financial Corp with notifications on news.